ABO zygosity, but not secretor or Fc receptor status, is a significant risk factor for IVIG-Associated hemolysis
2018
TO THE EDITOR:
Although frequently effective[1][1],[2][2] and usually benign, high-dose (2 g/kg) intravenous immunoglobulin (IVIG) therapy can result in marked red blood cell (RBC) hemolysis, which in some cases is life threatening in severity.[3][3][⇓][4]-[5][5] The mechanism by which this
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
24
References
14
Citations
NaN
KQI